A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia

This trial tested the safety and efficacy of a regimen consisting of hydroxyurea followed by azacitidine, 75 mg/m(2) for 7 days, and gemtuzumab ozogamicin, 3 mg/m(2) on day 8, in older patients with newly diagnosed acute myeloid leukemia. Those achieving a complete remission received 1 consolidation...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nand, Sucha, Othus, Megan, Godwin, John E., Willman, Cheryl L., Norwood, Thomas H., Howard, Dianna S., Coutre, Steven E., Erba, Harry P., Appelbaum, Frederick R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2013
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3829116/
https://ncbi.nlm.nih.gov/pubmed/24092933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-06-506592
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados